Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Clinical Emerging Investigator

Novo Nordisk Foundation

To support and strengthen the development of young and promising clinical research leaders and promote Danish clinical and translational research at a high international level, the Novo Nordisk Foundation seeks to support the starting clinical research leaders with ambitions of combining their clinical work with clinically relevant research

Specialties

Others

Eligibility Requirements

The project must be a 5-year project, and it must be anchored at a Danish university, hospital or other non-profit research institution.

Applicants must be a medical doctor and should have a Ph.D. or a dr. med. degree.
Applicants must be either ready to start or be under their medical specialist training. KBU and the introductory position must be completed (at the time of application deadline) if applicants are not yet under medical specialist training. Applicants may not have ended their medical specialist training at the time of application deadline.
It is essential that applicant’s own salary must be covered throughout the entire 5-year project period. 
Applicants must commit to minimum 20% (1 workday) and maximum 60% (3 workdays) research time, leaving from 80% (4 workdays) to 40% (2 workdays) to clinical work at a Danish hospital. The amount of time dedicated to research and clinical work can vary over the five project years, as it best fits the project and applicant. It must be specified how much time will be spent on research – under the tab ‘Applicant Information/’supplementary information’.
Applicants must have institutional support from the heads of both the clinical department and the department where the research is to be performed (hosting and support letters must be uploaded to the application, please see section 3.6 for further information).
Upon granting, it is the applicant’s responsibility to establish an agreement with the regional council on postgraduate medical training for their individual case.
‘Clinical Emerging Investigator’ grants are individual grants at the disposal of the applicant. If the applied project involves collaboration, the collaboration and the nature of the collaboration should be described in the project description, but the applicant must be the clear driver of the project (it is not possible to have or register co-applicants for this specific call).

Eligible Countries:

Denmark

Sponsor Details

Sponsor Institute/Organizations: Novo Nordisk Foundation

Sponsor Type: Corporate/Non-Profit

Address: Tuborg Havnevej 19 2900 Hellerup Denmark

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity